RIPE-KG · Version 1.1.0 · Resource

ripekg:study-design-evidence/RIPEA534C4E03EC302AE0

https://w3id.org/ripe/ripe-kg/study-design-evidence/RIPEA534C4E03EC302AE0
SubjectPredicateObject
ripekg:evaluation/RIPEA534C4E03EC302AE0 prov:used ripekg:study-design-evidence/RIPEA534C4E03EC302AE0
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 rdf:type rdfs:Resource
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 rdf:type owl:Thing
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 rdf:type ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 rdf:type ripe:StudyDesignEvidenceStudy design evidence
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 rdf:type tido:Evidence
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA534C4E03EC302AE0
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA534C4E03EC302AE0
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 ripe:concerns ripekg:work/10.3109%2F14767058.2014.954241RETRACTED ARTICLE: Effect of multivitamin versus multivitamin-mineral supplementation on metabolic profiles and biomarkers of oxidative stress in pregnant women: a double-blind randomized clinical trial
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 ripe:recruitmentEndDateExtractionRationale No direct LPI; range end is not used for recruitment_finish.
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 ripe:recruitmentStartDate 10-2011
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 ripe:recruitmentStartDateExtractionRationale Methods section: 'This randomized double-blind controlled clinical trial was carried out in Kashan, Iran during October 2011 to June 2012.' Used start of conducted range as recruitment_start per rule 5; no specific FPI elsewhere.
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 ripe:studyEndDate 06-2012
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 ripe:studyEndDateExtractionRationale Methods section: 'This randomized double-blind controlled clinical trial was carried out in Kashan, Iran during October 2011 to June 2012.' Used end of conducted range as study_end_date per rule 5; no specific completion date.
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 tido:supports ripekg:integrity-assessment-hypothesis/RIPEA534C4E03EC302AE0-human-2-2
ripekg:study-design-evidence/RIPEA534C4E03EC302AE0 tido:supports ripekg:integrity-assessment-hypothesis/RIPEA534C4E03EC302AE0-inspectai-2-2